logo

FBIO

Fortress Biotech·NASDAQ
--
--(--)
--
--(--)
4.03 / 10
Netural

FBIO's fundamentals score 4.03/10, indicating average standing. Key positives include a solid interest-coverage ratio (EBIT/Interest expense = 15.48%), while revenue growth (YoY 10.88%) is offset by a high days-sales-outstanding (80.73). Net income-revenue and profit-MV factors lean constructive, but asset-MV and cash-MV show weakness. Overall, the company maintains operational liquidity but faces working-capital and growth challenges.

Fundamental(4.03)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value-0.18
Score2/3
Weight18.35%
1M Return7.73%
Total operating revenue (YoY growth rate %)
Value10.88
Score1/3
Weight-1.37%
1M Return-0.79%
Days sales outstanding
Value80.73
Score0/3
Weight-8.28%
1M Return-5.18%
Profit-MV
Value0.46
Score2/3
Weight18.70%
1M Return8.45%
Net income-Revenue
Value0.94
Score2/3
Weight18.71%
1M Return8.45%
PB-ROE
Value-0.45
Score3/3
Weight25.35%
1M Return12.83%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.87%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value10.88
Score1/3
Weight-1.32%
1M Return-0.76%
Asset-MV
Value-0.50
Score0/3
Weight13.35%
1M Return5.75%
Cash-MV
Value-0.07
Score2/3
Weight18.38%
1M Return8.41%
Is FBIO fundamentally strong?
  • FBIO scores 4.03/10 on fundamentals and holds a Fair valuation at present. Backed by its 13.58% ROE, -86.41% net margin, -4.22 P/E ratio, 1.56 P/B ratio, and 96.62% earnings growth, these metrics solidify its Netural investment rating.